Smith & Nephew plc (LON:SN) shares rose 0% during trading on Thursday . The stock traded as high as GBX 1,326 ($17.44) and last traded at GBX 1,344 ($17.68). Approximately 2,050,291 shares were traded during trading, a decline of 44% from the average daily volume of 3,640,000 shares. The stock had previously closed at GBX 1,344 ($17.68).
SN has been the topic of several analyst reports. Citigroup Inc. restated a “sell” rating and set a GBX 1,160 ($15.26) price target on shares of Smith & Nephew plc in a research note on Friday, October 6th. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and issued a GBX 1,380 ($18.15) target price on shares of Smith & Nephew plc in a research note on Monday, September 11th. Berenberg Bank reiterated a “hold” rating and issued a GBX 1,340 ($17.62) target price on shares of Smith & Nephew plc in a research note on Friday, November 3rd. Jefferies Group LLC reiterated a “buy” rating and issued a GBX 1,515 ($19.93) target price on shares of Smith & Nephew plc in a research note on Monday, November 6th. Finally, J P Morgan Chase & Co reiterated a “neutral” rating and issued a GBX 1,361 ($17.90) target price on shares of Smith & Nephew plc in a research note on Tuesday, October 10th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. Smith & Nephew plc currently has a consensus rating of “Hold” and an average price target of GBX 1,302.83 ($17.14).
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this news story on another site, it was copied illegally and reposted in violation of United States and international trademark and copyright laws. The correct version of this news story can be viewed at https://transcriptdaily.com/2017/11/16/smith-nephew-plc-sn-stock-price-up-0.html.
Smith & Nephew plc Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.